BEAT - バイオテレメトリ― (BioTelemetry Inc.) バイオテレメトリ―

 BEATのチャート


 BEATの企業情報

symbol BEAT
会社名 BioTelemetry Inc (バイオテレメトリ―)
分野(sector) Health Care   ヘルスケア
産業(industry) Medical Specialities  
業種 ヘルスケア施設_サ―ビス   医療関連(Health Care)
概要 事業概要 バイオテレメトリー(BioTelemetry Inc.)はヘルスケア環境におけるモニタリングサービスとデジタル人口の健康管理、医療機器製造、臨床研究向けの集中化されたラボサービスを提供する。同社は3つの事業セグメントを有する。ヘルスケア事業は、CardioNet LLCとHeartcare Corporation of America Inc.として運営され、心臓不整脈または心臓リズム障害の診断・モニタリングに従事する。研究事業は、Cardiocore LLCとVirtualScopics Inc.として運営され、医薬品、医療、デバイス試験のための心臓モニタリング、イメージングサービス、科学的コンサルティング、データ管理サービスを提供するラボサービスに従事する。技術事業はBraemar Manufacturing LLC、Universal Medical Inc.、BioTelemetry Belgium BVBA.及びBioTelemetry Technology ApSとして運営され、ヘルスケア企業向けの非観血的な心臓モニターの製造・エンジニアリング・開発を行う。   バイオテレメトリ―は、米国の心臓監視サ―ビスのプロバイダ。心臓不整脈、心臓リズム障害の診断およびモニタリングのほか、医療企業、診療所や病院向けの心臓監視医療機器の開発、製造、販売を行う。また、薬剤と医療機器試験の心臓モニタリング、科学的なコンサルティングおよびデ―タ管理サ―ビスを提供する検査サ―ビスも提供。   BioTelemetry, Inc. provides monitoring services and digital population health management in a healthcare setting, medical device manufacturing and centralized core laboratory services for clinical research. The firm also develops proprietary integrated patient management platform that incorporates wireless data transmission network. It operates through the following segments: Healthcare, and Research. The Healthcare segment is focused on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. The Research segment is engaged in central core laboratory services providing cardiac monitoring, imaging services, scientific consulting and data management services for drug and medical device trials. The company was founded on April 22, 2013 and is headquartered in Malvern, PA.
本社所在地 1000 Cedar Hollow Road #102 Malvern PA 19355 USA
代表者氏名 Kirk E. Gorman カーク・ゴーマン
代表者役職名 Independent Chairman of the Board
電話番号 +1 610-729-7000
設立年月日 1994年
市場名 NASDAQ National Market System
ipoyear 2008年
従業員数 1600人
url https://www.gobio.com/
nasdaq_url https://www.nasdaq.com/symbol/beat
adr_tso
EBITDA EBITDA(百万ドル) 81.58800
終値(lastsale) 54
時価総額(marketcap) 1767058632
時価総額 時価総額(百万ドル) 1753.969
売上高 売上高(百万ドル) 368.62200
企業価値(EV) 企業価値(EV)(百万ドル) 1917.024
当期純利益 当期純利益(百万ドル) 6.54800
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 BioTelemetry Inc revenues increased 72% to $195.9M. Net income increased from $1.9M to $16.4M. Revenues reflect Helathcare segment increase of 93% to $167.3M Research segment increase of 26% to $23.8M. Net income benefited from Professional fees decrease of 47% to $1.8M (expense) Other Non Rec. I/E - Non Business Activ. increase of 16% to $700K (income).

 BEATのテクニカル分析


 BEATのニュース

   Outlook on the Cardiac Safety Services Global Market to 2026 - Featuring Bioclinica, BioTelemetry & Banook Group Among Others - ResearchAndMarkets.com  2020/08/14 10:32:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Global Cardiac Safety Services Market 2020-2026" report has been added to ResearchAndMarkets.com's offering. The global cardiac safety services market is estimated to grow significantly during the forecast period. The growth of the market is attributed to the increasing number of clinical trials, growing outsourcing of R&D services and increasing R&D investment coupled with pharmaceutical R&D across the globe. The growing R&D expenditure is also dri
   COVID-19 Impact and Recovery Analysis- Telemedicine Market 2020-2024 | Growing Burden of Chronic Diseases to Boost Growth | Technavio  2020/06/08 23:45:00 Benzinga Feeds
Technavio has been monitoring the telemedicine market and it is poised to grow by USD 56.47 billion during 2020-2024, progressing at a CAGR of almost 19% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200608005648/en/ Technavio has announced its latest market research report titled Global Telemedicine Market 2020-2024 (Graphic: Business Wire) Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Request for Technavio's latest reports on directly and indirectly impacted markets. Market estimates include pre- and post-COVID-19 impact on the Telemedicine Market Download free sample report The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Aerotel Medical Systems Ltd., Allscripts Healthcare Solutions Inc., BioTelemetry Inc., Cisco Systems Inc., General Electric Co., HP Inc., International Business Machines Corp., Koninklijke Philips NV, Medtronic Plc, and Siemens Healthineers AG are some of the major market participants.
   Is a Surprise Coming for BioTelemetry (BEAT) This Earnings Season?  2020/04/22 12:44:00 Zacks Investment Research
BioTelemetry (BEAT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
   BioTelemetry (BEAT) to Report Q1 Results: Wall Street Expects Earnings Growth  2020/04/16 16:31:39 Zacks Investment Research
BioTelemetry (BEAT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection  2020/03/19 11:37:15 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) Biomerica, Inc. (NASDAQ: BMRA )( announced commencement of international shipment of rapid COVID-19 test) BioNTech SE – ADR (NASDAQ: BNTX ) Imara Inc (NASDAQ: IMRA ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on March 18) 89bio Inc (NASDAQ: ETNB ) AC Immune SA (NASDAQ: ACIU ) Acasti Pharma Inc (NASDAQ: ACST ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adamis Pharmaceuticals Corp (NASDAQ: ADM ) Adial Pharmaceuticals Inc (NASDAQ: ADIL ) ADMA Biologics Inc (NASDAQ: ADMA ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Agenus Inc (NASDAQ: AGEN ) Agios Pharmaceuticals Inc (NASDAQ: AGIO ) Aikido Pharma Inc (NASDAQ: AIKI ) Akorn, Inc. (NASDAQ: AKRX ) Alkermes Plc (NASDAQ: ALKS ) Allogene Therapeutics Inc (NASDAQ: ALLO ) Alterity Therapeutics Ltd (NASDAQ: ATHE ) AMAG Pharmaceuticals, Inc.
   COVID-19 Impact and Recovery Analysis- Telemedicine Market 2020-2024 | Growing Burden of Chronic Diseases to Boost Growth | Technavio  2020/06/08 23:45:00 Benzinga Feeds
Technavio has been monitoring the telemedicine market and it is poised to grow by USD 56.47 billion during 2020-2024, progressing at a CAGR of almost 19% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200608005648/en/ Technavio has announced its latest market research report titled Global Telemedicine Market 2020-2024 (Graphic: Business Wire) Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Request for Technavio's latest reports on directly and indirectly impacted markets. Market estimates include pre- and post-COVID-19 impact on the Telemedicine Market Download free sample report The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Aerotel Medical Systems Ltd., Allscripts Healthcare Solutions Inc., BioTelemetry Inc., Cisco Systems Inc., General Electric Co., HP Inc., International Business Machines Corp., Koninklijke Philips NV, Medtronic Plc, and Siemens Healthineers AG are some of the major market participants.
   Is a Surprise Coming for BioTelemetry (BEAT) This Earnings Season?  2020/04/22 12:44:00 Zacks Investment Research
BioTelemetry (BEAT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
   BioTelemetry (BEAT) to Report Q1 Results: Wall Street Expects Earnings Growth  2020/04/16 16:31:39 Zacks Investment Research
BioTelemetry (BEAT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection  2020/03/19 11:37:15 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) Biomerica, Inc. (NASDAQ: BMRA )( announced commencement of international shipment of rapid COVID-19 test) BioNTech SE – ADR (NASDAQ: BNTX ) Imara Inc (NASDAQ: IMRA ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on March 18) 89bio Inc (NASDAQ: ETNB ) AC Immune SA (NASDAQ: ACIU ) Acasti Pharma Inc (NASDAQ: ACST ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adamis Pharmaceuticals Corp (NASDAQ: ADM ) Adial Pharmaceuticals Inc (NASDAQ: ADIL ) ADMA Biologics Inc (NASDAQ: ADMA ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Agenus Inc (NASDAQ: AGEN ) Agios Pharmaceuticals Inc (NASDAQ: AGIO ) Aikido Pharma Inc (NASDAQ: AIKI ) Akorn, Inc. (NASDAQ: AKRX ) Alkermes Plc (NASDAQ: ALKS ) Allogene Therapeutics Inc (NASDAQ: ALLO ) Alterity Therapeutics Ltd (NASDAQ: ATHE ) AMAG Pharmaceuticals, Inc.
   The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings  2020/03/13 11:52:53 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) Masimo Corporation (NASDAQ: MASI ) Down In The Dumps (Biotech stocks that hit 52-week lows March 12.) Abbott Laboratories (NYSE: ABT ) ABIOMED, Inc. (NASDAQ: ABMD ) Acasti Pharma Inc (NASDAQ: ACST ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Achieve Life Sciences Inc (NASDAQ: ACHV ) Acorda Therapeutics Inc (NASDAQ: ACOR ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adamis Pharmaceuticals Corp (NASDAQ: ADM ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) ADMA Biologics Inc (NASDAQ: ADMA ) Aeglea Bio Therapeutics Inc (NASDAQ: AGLE ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Affimed NV (NASDAQ: AFMD ) Aileron Therapeutics Inc (NASDAQ: ALRN ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Akari Therapeutics PLC (NASDAQ: AKTX ) Akcea Therapeutics Inc (NASDAQ: AKCA ) Akero Therapeutics Inc (NASDAQ: AKRO ) Akers Biosciences Inc (NASDAQ: AKER ) Akorn, Inc.
   COVID-19 Impact and Recovery Analysis- Telemedicine Market 2020-2024 | Growing Burden of Chronic Diseases to Boost Growth | Technavio  2020/06/08 23:45:00 Benzinga Feeds
Technavio has been monitoring the telemedicine market and it is poised to grow by USD 56.47 billion during 2020-2024, progressing at a CAGR of almost 19% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200608005648/en/ Technavio has announced its latest market research report titled Global Telemedicine Market 2020-2024 (Graphic: Business Wire) Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Request for Technavio's latest reports on directly and indirectly impacted markets. Market estimates include pre- and post-COVID-19 impact on the Telemedicine Market Download free sample report The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Aerotel Medical Systems Ltd., Allscripts Healthcare Solutions Inc., BioTelemetry Inc., Cisco Systems Inc., General Electric Co., HP Inc., International Business Machines Corp., Koninklijke Philips NV, Medtronic Plc, and Siemens Healthineers AG are some of the major market participants.
   Is a Surprise Coming for BioTelemetry (BEAT) This Earnings Season?  2020/04/22 12:44:00 Zacks Investment Research
BioTelemetry (BEAT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
   BioTelemetry (BEAT) to Report Q1 Results: Wall Street Expects Earnings Growth  2020/04/16 16:31:39 Zacks Investment Research
BioTelemetry (BEAT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection  2020/03/19 11:37:15 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) Biomerica, Inc. (NASDAQ: BMRA )( announced commencement of international shipment of rapid COVID-19 test) BioNTech SE – ADR (NASDAQ: BNTX ) Imara Inc (NASDAQ: IMRA ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on March 18) 89bio Inc (NASDAQ: ETNB ) AC Immune SA (NASDAQ: ACIU ) Acasti Pharma Inc (NASDAQ: ACST ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adamis Pharmaceuticals Corp (NASDAQ: ADM ) Adial Pharmaceuticals Inc (NASDAQ: ADIL ) ADMA Biologics Inc (NASDAQ: ADMA ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Agenus Inc (NASDAQ: AGEN ) Agios Pharmaceuticals Inc (NASDAQ: AGIO ) Aikido Pharma Inc (NASDAQ: AIKI ) Akorn, Inc. (NASDAQ: AKRX ) Alkermes Plc (NASDAQ: ALKS ) Allogene Therapeutics Inc (NASDAQ: ALLO ) Alterity Therapeutics Ltd (NASDAQ: ATHE ) AMAG Pharmaceuticals, Inc.
   The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings  2020/03/13 11:52:53 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) Masimo Corporation (NASDAQ: MASI ) Down In The Dumps (Biotech stocks that hit 52-week lows March 12.) Abbott Laboratories (NYSE: ABT ) ABIOMED, Inc. (NASDAQ: ABMD ) Acasti Pharma Inc (NASDAQ: ACST ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Achieve Life Sciences Inc (NASDAQ: ACHV ) Acorda Therapeutics Inc (NASDAQ: ACOR ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adamis Pharmaceuticals Corp (NASDAQ: ADM ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) ADMA Biologics Inc (NASDAQ: ADMA ) Aeglea Bio Therapeutics Inc (NASDAQ: AGLE ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Affimed NV (NASDAQ: AFMD ) Aileron Therapeutics Inc (NASDAQ: ALRN ) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Akari Therapeutics PLC (NASDAQ: AKTX ) Akcea Therapeutics Inc (NASDAQ: AKCA ) Akero Therapeutics Inc (NASDAQ: AKRO ) Akers Biosciences Inc (NASDAQ: AKER ) Akorn, Inc.

 関連キーワード  (ヘルスケア施設_サ―ビス 米国株 バイオテレメトリ― BEAT BioTelemetry Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)